LCM
ACET icon

Landscape Capital Management’s Adicet Bio ACET Stock Holding History

Landscape Capital Management’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,115
Closed -$10.9K – 608
2025
Q2 		$10.9K Buy
+1,115
New +$11.8K ﹤0.01% 625

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Landscape Capital Management's ACET Position: Q3 2025 in Review

Landscape Capital Management sold out of Adicet Bio (ACET) in Q3 2025, closing a stake of 1,115 shares — an estimated $10.9K sold.

Landscape Capital Management first reported a position in ACET in Q2 2025 and held it in 1 quarter. The position peaked at $10.9K in Q2 2025. 54 funds tracked by Wall St. Rank hold ACET as of Q3 2025.

  • Landscape Capital Management reported no remaining Adicet Bio position as of Q3 2025 after selling out during the quarter.
  • Landscape Capital Management sold 1,115 Adicet Bio shares in Q3 2025, an estimated $10.9K.
  • Landscape Capital Management first reported a position in Adicet Bio in Q2 2025 and held it in 1 quarter.
  • Landscape Capital Management's Adicet Bio position peaked at $10.9K in Q2 2025.
  • 54 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2025.

Based on Landscape Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.